Threshold for optimal administration of plerixafor in autologous peripheral blood stem cell collections through CD34+ cell monitoring based on the experience from two Japanese university hospitals
暂无分享,去创建一个
N. Komatsu | Y. Araki | A. Ohsaka | K. Miyake | M. Noguchi | K. Yamatoya | M. Okubo | Y. Sekiguchi | Yoshiaki Furuta | Yuki Nakamura | Toshiya Osawa | N. Tada | T. Sawada | Y. Furuta | Y. Nakamura